Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an average price of $22.48, for a total value of $674,400.00. Following the sale, the president owned 1,027,015 shares in the company, valued at $23,087,297.20. This represents a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Dawn Christine Maroney also recently made the following trade(s):
- On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total value of $4,866,482.16.
- On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total transaction of $2,003,000.00.
- On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80.
- On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total transaction of $2,267,513.19.
- On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62.
Alignment Healthcare Price Performance
Shares of ALHC opened at $22.50 on Friday. The stock has a market cap of $4.50 billion, a PE ratio of -187.50, a price-to-earnings-growth ratio of 5.92 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.19. The firm’s 50-day simple moving average is $19.21 and its two-hundred day simple moving average is $16.83.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the company. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday. Cowen restated a “buy” rating on shares of Alignment Healthcare in a research note on Friday. TD Cowen lifted their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday. JPMorgan Chase & Co. increased their price target on shares of Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Finally, KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $21.86.
Check Out Our Latest Research Report on Alignment Healthcare
Institutional Trading of Alignment Healthcare
A number of institutional investors have recently made changes to their positions in the stock. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 167.3% during the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after purchasing an additional 6,940,277 shares during the last quarter. Invesco Ltd. grew its position in Alignment Healthcare by 122.3% in the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock worth $58,387,000 after purchasing an additional 2,294,739 shares during the period. Assenagon Asset Management S.A. raised its stake in Alignment Healthcare by 6,708.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,774,975 shares of the company’s stock valued at $35,056,000 after buying an additional 1,748,903 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Alignment Healthcare by 173.3% during the 2nd quarter. Marshall Wace LLP now owns 2,039,714 shares of the company’s stock valued at $28,556,000 after buying an additional 1,293,416 shares during the period. Finally, Voya Investment Management LLC boosted its stake in shares of Alignment Healthcare by 61.0% in the 3rd quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company’s stock worth $55,775,000 after buying an additional 1,210,930 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.
Alignment Healthcare Company Profile
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Read More
- Five stocks we like better than Alignment Healthcare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street Alert: Buy AES
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
